APA (7th ed.) Citation

Nichols, R., Skljarevski, V., Dell’Agnello, G., Hundemer, H., & Aurora, S. K. (2019). Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. Journal of headache and pain, 20(1), 22-2. https://doi.org/10.1186/s10194-019-0975-2

Chicago Style (17th ed.) Citation

Nichols, Russell, Vladimir Skljarevski, Grazia Dell’Agnello, Hans-Peter Hundemer, and Sheena K. Aurora. "Letter to the Editor Regarding European Headache Federation Guideline on the Use of Monoclonal Antibodies Acting on the Calcitonin Gene Related Peptide or Its Receptor for Migraine Prevention." Journal of Headache and Pain 20, no. 1 (2019): 22-2. https://doi.org/10.1186/s10194-019-0975-2.

MLA (9th ed.) Citation

Nichols, Russell, et al. "Letter to the Editor Regarding European Headache Federation Guideline on the Use of Monoclonal Antibodies Acting on the Calcitonin Gene Related Peptide or Its Receptor for Migraine Prevention." Journal of Headache and Pain, vol. 20, no. 1, 2019, pp. 22-2, https://doi.org/10.1186/s10194-019-0975-2.